Replimune Group, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
51.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
5
|
|
# Buys
|
5
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.78
|
-0.79
|
-0.01
|
-1.28%
|
|
2022-06-30
|
-0.64
|
-0.78
|
-0.14
|
-21.88%
|
|
2022-03-31
|
-0.58
|
-0.60
|
-0.02
|
-3.45%
|
|
2021-12-31
|
-0.58
|
-0.57
|
0.01
|
1.72%
|
|
2021-09-30
|
-0.54
|
-0.56
|
-0.02
|
-3.70%
|
|
2021-06-30
|
-0.46
|
-0.53
|
-0.07
|
-15.22%
|
|
2021-03-31
|
-0.41
|
-0.41
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.42
|
-0.44
|
-0.02
|
-4.76%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.57
|
|
2022-03-31
|
-2.26
|
|
2021-03-31
|
-1.75
|
|
2020-03-31
|
-1.52
|
|
2019-03-31
|
-2.67
|
|
2018-03-31
|
-0.42
|